Investigational New Drug CDMO Market Share

Statistics for the 2023 & 2024 Investigational New Drug CDMO market share, created by Mordor Intelligence™ Industry Reports. Investigational New Drug CDMO share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Investigational New Drug CDMO Market Market Share

Market Share of Investigational New Drug CDMO Industry

The investigational new drug CDMO market is semi-consolidated, with several companies operating globally. Most companies are engaged in strategic activities like mergers and acquisitions, collaborations, and partnerships to sustain in the market. Some of the key players involved in the market are Lonza, Charles River Laboratories International Inc., Labcorp Corporation, Recipharm AB, and Syneous Health.

Investigational New Drug CDMO Market Leaders

  1. Lonza

  2. Charles River Laboratories International, Inc.

  3. Recipharm AB

  4. Syneous Health

  5. Labcorp Corporation

*Disclaimer: Major Players sorted in no particular order

Investigational New Drug CDMO Market Concentration

Investigational New Drug CDMO Market Report Snapshots

Investigational New Drug CDMO Market Size & Share Analysis - Growth, Trends and Forecasts (2024-2029)